Search for: "Janssen Pharmaceutica Inc"
Results 1 - 20
of 64
Sort by Relevance
|
Sort by Date
5 Dec 2022, 6:55 am
The court granted Teva’s motion, finding the facts analogous to the Federal Circuit’s decision in Janssen Pharmaceutica, N.V. v. [read post]
5 Dec 2022, 6:55 am
The court granted Teva’s motion, finding the facts analogous to the Federal Circuit’s decision in Janssen Pharmaceutica, N.V. v. [read post]
5 Dec 2022, 6:55 am
The court granted Teva’s motion, finding the facts analogous to the Federal Circuit’s decision in Janssen Pharmaceutica, N.V. v. [read post]
14 Dec 2021, 9:57 am
Janssen Pharmaceutica, N.V., No. 21-202. [read post]
27 Oct 2021, 5:15 am
Janssen Pharmaceutica, N.V., No. 21-202 (NHK-Fintiv rule for denying petitions; appealability of IPR petition denial); Apple Inc. v. [read post]
20 Sep 2021, 3:31 pm
Janssen Pharmaceutica (appealing institution denials); Apple Inc. v. [read post]
2 Sep 2020, 1:45 pm
The Defendants named in a typical lawsuit filed on behalf of an Elmiron user who developed vision problems might be some combination of the following: JANSSEN PHARMACEUTICALS, INC., f/k/a Ortho-McNeil-Janssen Pharmaceuticals, Inc., f/k/a Janssen Pharmaceutica Inc. [read post]
21 Jun 2018, 10:33 am
It was first developed by Janssen Pharmaceutica around 1960 and approved for American medical use in 1968 as an injectable anesthetic called Sublimaze. [read post]
13 Feb 2015, 11:43 am
Janssen Pharmaceutica, Inc., 2006 WL 3665417, at *4 n.2 (S.D. [read post]
21 Jan 2015, 9:40 am
Janssen Pharmaceutica, Inc., 288 F. [read post]
31 Dec 2014, 5:00 am
Janssen Pharmaceutica, Inc., 144 So.3d 898 (La. 2014). [read post]
28 Jan 2014, 10:33 am
Janssen Pharmaceutica, Inc., Nos. [read post]
7 Nov 2013, 11:24 pm
”Add caption Starr, a former sales representative for Janssen Pharmaceutica, a wholly-owned subsidiary of drugmaker Johnson & Johnson, felt as if she was being encouraged and pressured to market Risperdal off-label. [read post]
26 Mar 2013, 7:17 am
South Carolina Lawyers Weekly ran an article last week concerning Janssen Pharmaceutica's appeal of a $327 million penalty handed down by Judge Robert Couch in 2011. [read post]
16 Apr 2012, 9:49 pm
Cir. 2008), and Janssen Pharmaceutica, N.V. v. [read post]
24 Jan 2012, 6:34 pm
Cir. 2008) and Janssen Pharmaceutica, N.V. v. [read post]
13 Jun 2011, 4:30 am
Earlier this month, the State of South Carolina was awarded $327 million in damages from drugmaker Janssen Pharmaceutica, Inc., a Johnson & Johnson subsidiary, under the state’s Unfair Trade Practices Act for deceptive marketing of its anti-psychotic drug, Risperdal. [read post]
2 Jun 2011, 12:46 pm
Wyeth Inc., 488 F. [read post]
2 May 2011, 4:30 am
A Spartanburg, South Carolina judge is set to decide how much money Janssen Pharmaceutica, Inc., a Johnson & Johnson subsidiary, should pay the state for what the jury found to be deceptive marketing by the company of its antipsychotic drug Risperdal. [read post]
29 Apr 2011, 7:43 am
Janssen Pharmaceutica Inc. [read post]
